What is CorMedix's EV / sales?

CorMedix (CRMD) reported EV / sales of 2.5× in Q4 2025.

How has CorMedix's EV / sales changed year-over-year?

CorMedix's EV / sales decreased by 76.1% year-over-year, from 10.4× to 2.5×.

What is the long-term trend for CorMedix's EV / sales?

Over 4 years (2020 to 2025), CorMedix's EV / sales has grown at a -77.7% compound annual growth rate (CAGR), from 1,011.2× to 2.5×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

CorMedix CRMD EV / sales

EV / sales at other companies

PfizerPFE

3.5×+0.3×

Merck & Co.MRK

5.2×+1.2×

Merit Medical SystemsMMSI

2.9×-1.9×

ITG

Integer HoldingsITGR

2.4×-0.8×

IAR

Integra LifeSciencesIART

1.5×-0.6×

Emergent BiosolutionsEBS

1.3×+0.4×

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Calculated from CorMedix’s reported figures.

enterprise value/total revenue=2.5×

Based on the most recent quarter.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's EV / sales?: CorMedix (CRMD) reported EV / sales of 2.5× in Q4 2025.
How has CorMedix's EV / sales changed year-over-year?: CorMedix's EV / sales decreased by 76.1% year-over-year, from 10.4× to 2.5×.
What is the long-term trend for CorMedix's EV / sales?: Over 4 years (2020 to 2025), CorMedix's EV / sales has grown at a -77.7% compound annual growth rate (CAGR), from 1,011.2× to 2.5×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.